Search
forLearn
5 / 801 resultslearn HMI-115
much-hyped research compound targeting prolactin receptor in scalp
learn Shatavari
learn amla
learn Ayurvedic herb blend
Research
5 / 99 resultsresearch A Comparative Study to Evaluate the Efficacy of Asthisrinkala Lepa and Thriphala Mashi with Pracchanna in the Management of Indraluptha w.s.r. to Alopecia Areata
Asthisrinkala lepa is more effective than Triphala mashi lepa for treating Alopecia areata.
research Management of Indralupta with Prachana and External Applications - A Case Report
Ayurvedic treatment with Prachana and external applications effectively promoted hair regrowth in alopecia areata.
research A CASE STUDY ON AYURVEDIC MANAGEMENT OF ALOPACIA AREATA- THROUGH EXTERNAL TREATMENT
Ayurvedic treatment led to significant hair regrowth in alopecia areata.
research Clinical Outcome of Ayurvedic Management of Indralupta (Alopecia Areata)- A Case Study
Ayurvedic treatment may help manage alopecia areata.
research MANAGEMENT OF INDRALUPTA- A CASE REPORT
Ayurvedic treatments successfully regrew hair and reduced hair loss in a woman with alopecia areata.
Community Join
5 / 1000+ resultscommunity Anyone from India wants to try Pyrilutamide?
A user offers an extra bottle of Koshine 0.5% solution for hair loss. The discussion involves interest in trying Pyrilutamide for hair treatment.
community How to buy pyrilutamide in India
Purchasing Pyrilutamide for hair loss treatment in India, and exploring the possibility of utilizing Minoxidil, Finasteride, and RU58841 as alternatives.
community What's going on with hmi115? The Phase 2 was concluded Nov2024 but no news
Hmi115, a prolactin receptor blocker, showed promise for hair growth, but results from Phase 2 trials have not been published. ABS-201, an AI-based analog, is expected to begin trials in December 2025, while commercialization of treatments like PP-405 is anticipated around 2027.
community HLT Megathread on HMI-115 (key takeaways in comments)
HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.
community Does the HMI-115 actually have potential or is it another false hope?
Hair loss discussion includes potential HMI-115 treatment. Topical mucuna pruriens shows good results, blocking prolactin possibly more important than blocking DHT.